Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

FA302013P0006

Contract

Obligated and Ceiling

Obligated (net)
$666,791.00
Ceiling (potential value, not spending)
$666,791.00
Current value
$666,791.00
Gross positive obligations
$771,426.74

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
Awarding agency
Department of War · sub-agency 5700 · office FA3020
Funding agency
Department of War · sub-agency 5700
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
FA302013P0006
Award type code
B
Actions
19 · Nov 26, 2012 to Aug 15, 2017
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History19

Award actions
DateFYModAction typeObligationCompany in company totals
Aug 15, 2017FY2017P00018C−$47,628.17
—
Jun 27, 2017FY2017P00017M$0.00
—
Jun 2, 2017FY2017P00016M$0.00
—
Jan 25, 2017FY2017P00015B−$7,007.57
—
Oct 1, 2016FY2017P00014C$163,355.71
—
Sep 20, 2016FY2016P00013G$0.00
—
Oct 23, 2015FY2016P00012M$0.00
—
Oct 2, 2015FY2016P00011M$163,355.71
—
Sep 10, 2015FY2015P00010G−$20,000.00
—
Oct 1, 2014FY2015P00009M$161,148.01
—
Sep 23, 2014FY2014P00008G$0.00
—
Oct 1, 2013FY2014P00007M$161,148.01
—
Aug 23, 2013FY2013P00006M−$30,000.00
—
Aug 8, 2013FY2013P00005M$0.00
—
Jul 18, 2013FY2013P00004M$0.00
—
Jun 18, 2013FY2013P00003D$0.00
—
Jun 17, 2013FY2013P00002D$6,233.17
—
Dec 21, 2012FY2013P00001D$0.00
—
Nov 26, 2012FY20130—$116,186.13
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.